Financials
Financial year 2025
Phytant from Wingene, company number BE0777636528, closed financial year 2025 with a result of € 5,582 after tax. For that financial year Phytant recorded a gross margin of € -2,064 and equity of € 211,826. Compared with financial year 2024, the result moved from € 4,600 to € 5,582. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on November 26, 2025.
€ 211,826
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 5,582
▲ 21% vs 2024
Profit after tax over the fiscal year.
€ 130,689
▼ 59% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 11,826.
Debts at end 2025
€ 550,000
Loans from banks and other lenders, long and short.
€ 9,676
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -1,554 | € -2,015 | € -2,064 | ▼ € 49 |
| Profit after taxes | € 1,644 | € 4,600 | € 5,582 | ▲ 21% |
| Equity | € 201,644 | € 206,244 | € 211,826 | ▲ 3% |
| Total debts | € 150,309 | € 550,000 | € 559,676 | ▲ 2% |
| Cash | € 74,665 | € 319,444 | € 130,689 | ▼ 59% |
| Retained profit | € 1,644 | € 6,244 | € 11,826 | ▲ 89% |
| Bank debt | € 150,000 | € 550,000 | € 550,000 | |
| Balance sheet total | € 351,952 | € 756,244 | € 771,502 | ▲ 2% |
Key figures of Phytant, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 November 2026.
What happened to Phytant?
What happened at Phytant in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- THIERRY BOGAERT stepped down as director. NBB
- MYRMEX BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 5,582 (▲ 21% vs 2024). Source: NBB ↗
- New establishment in Wingene. KBO
- Start of the company according to the CBE. KBO
- THIERRY BOGAERT became a director. NBB
- MYRMEX BV became a director. NBB
In short
From € 1,644 profit in 2023 to € 5,582 profit in 2025.
Best year ever: 2025, with € 5,582 profit.
Management
Directors
According to the 2025 annual accounts
since 2021 · until 2027
Managing director · represented by JAN BOGAERT
Also active at: APIX Biosciences, Mellona Partners
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Blauwhuisstraat 11
8750 Wingene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →ALASAN
PARANG
Mellona
APIX Biosciences same network
€ -149,150 gross margin · 2025
MYRMEX same network
€ 49,468 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0777.636.528
- VAT number
- BE 0777.636.528
- Registered office
- Blauwhuisstraat 11, 8750 Wingene
- Names & denominations
- Phytant
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 November 2021
- Peppol
- Active · Active since 15 Jul 2024
- Activities · NACE
Markt- en opinieonderzoek
Speur- en ontwikkelingswerk op biotechnologisch gebied
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige gespecialiseerde wetenschappelijke en technische activiteiten